ClinicalTrials.Veeva

Menu

Metabolic Impact of Fat Digestion (LIPINFLOX)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Unknown

Conditions

Obesity

Treatments

Other: All subjects receive three sequences of a standard breakfast

Study type

Interventional

Funder types

Other

Identifiers

NCT01249378
2009.563/16

Details and patient eligibility

About

In this study, the investigators are interested in investigating how the emulsification state and amount of fat in a meal can modify the kinetics of postprandial lipemia and inflammatory outcomes (including endotoxemia) in obese vs lean subjects.

10 lean and 10 obese volunteers will come 3 times (>3 weeks apart) at the investigation center to receive a standard breakfast containing milk fat (10 g non emulsified, or 40 g non emulsified, or 40 g finely emulsified). 13C triglyceride stable isotopes will allow to follow the metabolic fate of fatty acids and calculate lipid oxidation by breath test. Blood sampling throughout digestion will allow to measure metabolic, lipid and inflammation parameters. Stool will be analysed to determine lipid losses in faeces and to phenotype microbiota.

Enrollment

20 estimated patients

Sex

Male

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • No smokers
  • BMI 18 to 35 kg/m2
  • Moderate physical activity
  • Safety subject during medical consultation

Exclusion criteria

  • Medical history which may affect lipid metabolism and gut microflora (renal -cardiovascular -hepatic- endocrine-inflammatory diseases)
  • Drug use that could affect lipid metabolism and gut microflora (steroids, antilipemic agent, anorectic, antibiotic)
  • Inflammatory or infectious disease in the last three month
  • C Reactive Protein > 20
  • Prebiotic or probiotic high consumers (several times a day)
  • Eating disorder
  • Claustrophobic subjects

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

20 participants in 3 patient groups

10 g non emulsified of milk fat
Active Comparator group
Description:
They are compared using the repeated measurements taken within subjects
Treatment:
Other: All subjects receive three sequences of a standard breakfast
40 g non emulsified of milk fat
Active Comparator group
Description:
The subjects receive three sequences of different breakfasts. They are compared using the repeated measurements taken within subjects.
Treatment:
Other: All subjects receive three sequences of a standard breakfast
40 g finely emulsified of milk fat
Active Comparator group
Description:
The subjects receive three sequences of different breakfasts. They are compared using the repeated measurements taken within subjects.
Treatment:
Other: All subjects receive three sequences of a standard breakfast

Trial contacts and locations

1

Loading...

Central trial contact

Martine LAVILLE, PU-PU

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems